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Abstract
Previous American Telemedicine Association (ATA) Tele-
dermatology Practice Guidelines were issued in 2007. This
updated version reflects new knowledge in the field, new
technologies, and the need to incorporate teledermatology
practice in a variety of settings, including hospitals, urgent
care centers, Federally Qualified Health Centers, school-based
clinics, public health facilities, and patient homes.
Keywords: dermatology, education, teledermatology, telemedicine
Preamble
T
he American Telemedicine Association (ATA) brings
together diverse groups from traditional medicine,
academia, technology and telecommunications com-
panies, e-health, allied professional and nursing
associations, medical associations, government, military, reg-
ulatory, and others to address and advance compliance with
legal, ethical, and professional standards in the practice
of telemedicine.
ATA has embarked on an organized effort to establish
guidelines for the practice of telemedicine in various clinical
applications to assure uniform quality of service for patients
and providers, to enhance patient experience, and to enable
providers to deliver appropriate care. The guidelines are de-
veloped by panels that include experts from the field and other
strategic stakeholders, and are designed to serve as a standard
reference and educational tool for professionals to provide
appropriate care for patients. The process for developing these
guidelines is based on professional consensus and a rigorous
review, including open public commentary period, with final
approval by the ATA Board of Directors. Guidelines are re-
viewed and updated periodically.
The purpose of these guidelines is to assist providers in
pursuing a sound course of action in providing effective and
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safe medical care that is founded on current scientific
knowledge, technological requirements, and patient needs.
Safe and effective practice requires technical training, pro-
fessional knowledge and skill, and explicit processes, as de-
scribed in each document. All guidelines issued by the ATA
are properties of the ATA. Any modification or reproduction
of the published guideline must receive prior approval by
the ATA.
Compliance with these guidelines alone will not guarantee
accurate diagnoses, appropriate clinical treatment, or optimal
outcomes. A divergence from the guidelines may be indicated
under certain conditions, such as emergency situations in places
with limited resources that call for prompt action to attend to
the patient. Similarly, technological advances may alter pre-
vailing practices or provide new and expanded opportunities.
The technical and administrative guidelines in this docu-
ment do not purport to establish binding legal standards for
delivering telemedicine services. They are based on the ac-
cumulated knowledge and experience of the ATA workgroups
and other professionals.
. The previous ATA Teledermatology Practice Guidelines
were issued in 2007. This is the revised version reflecting
new knowledge in the field, new technologies, and the
need to incorporate teledermatology practice in a variety
of settings, including hospitals, urgent care centers,
Federally Qualified Health Centers, school-based clinics,
public health facilities, and patient homes.
Scope
The teledermatology guidelines apply to individual pro-
viders, group and specialty practices, hospitals and healthcare
systems when providing services via information and com-
munication technology (ICT) as a substitute for or an adjunct
to in-person care.
The users of these guidelines are urged to review and
comply with professional guidelines within their domain of
practice as they pertain to prevention, diagnosis, treatment,
and follow-up of skin disorders.
These guidelines pertain primarily to healthcare providers
and patients located in the United States (U.S.). When either or
both parties are not within the jurisdiction of the United
States, applicable local guidelines and protocols take prece-
dence according to the rules of prevailing jurisdictions.1,2
The guidelines address three aspects of service delivery:
clinical, technical, and administrative. Under each set, the
guidelines are classified according to four levels of adherence:
. ‘‘Shall,’’ indicates required action or adherence whenever
feasible and/or practical.
. ‘‘Shall not’’ indicates a proscription or action that is
strongly advised against.
. ‘‘Should’’ indicates a recommended action without ex-
cluding others.
. ‘‘May’’ indicates pertinent actions that may be considered
to optimize the telemedicine encounter.
Introduction
The practice of dermatology is particularly suited to tele-
medicine because skin disorders are visible to the human eye,
and clinical information can be acquired, stored, and trans-
mitted for accurate diagnosis and appropriate treatment in the
majority of cases. Cases that require biopsy can also be iden-
tified and appropriate referral initiated promptly. The practice
of teledermatology can alleviate the maldistribution of spe-
cialty care and enable patients not located in the geographic
proximity of expert resource to receive care. The following
guidelines are designed to establish coherent, effective, safe,
and sustainable standards for the practice of teledermatology.
The guidelines cover three areas, reflecting the processes
associated with most teledermatology consultations: Clinical
Practice, Technical Requirements, and Administration. They
may be used together with the Core Operational Guidelines for
Telemedicine Services Involving Provider-Patient Interac-
tions, and ATA Practice Guidelines3 for Live On Demand
Primary and Urgent Care (2014).4
These guidelines pertain to the three modes typically used
for teledermatology: store-and-forward (S&F) or transmitting
digital images and associated patient data to the specialist for
consultation at a later time; real-time video teleconferencing
(VTC) in which providers and patients interact via live vid-
eoconferencing; and hybrid (utilizing both S&F and VTC).
There is a growing body of evidence regarding the effec-
tiveness of synchronous and asynchronous teledermatology
for a variety of skin disorders that present in diverse practice
settings, including emergency departments, hospitals, pa-
tient homes, schools, chronic care facilities, the workplace,
and the military.
Teledermatology has been found to be reliable for accurate
diagnosis and treatment plans for skin disorders.5–41 With
some exceptions, the preponderance of the evidence confirms
the diagnostic accuracy of teledermatology compared to in-
person encounters,9,13,21,28,29,41–48 as well as management/
treatment recommendations.6,11–13,15,21–23,25,26,28–31,33,37,43,45–53
Clinical outcomes and quality-of-life measures are similar as
well for telemedicine and in-person care.54–64 Moreover,
patients, referring clinicians, and dermatologists have expressed
high levels of satisfaction with teledermatology,15,23,33,34,38,65–79
MCKOY ET AL.
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as it facilitates access to dermatologic expertise for patients
who are geographically or logistically challenged.
Practice Guidelines
In teledermatology, S&F communication typically refers to
the sending or forwarding of digital images and associated
patient data to the specialist for storage and consultation at a
later time. For real-time VTC, providers and patients interact
via live videoconferencing. These recommendations apply to
S&F, VTC, and hybrid (utilizing both S&F and VTC) modes for
teledermatology.
CLINICAL PRACTICE GUIDELINES
Many skin conditions lend themselves to a telemedicine
consult as defined in this document. Typically, these include
conditions for which there is reasonable certainty of estab-
lishing a diagnosis and generating a treatment plan on the basis
of visual information and access to a medical record. The ul-
timate decision for a teledermatology consult is made by
the patient, the referring provider, and the teledermatologist.
These guidelines define appropriate conditions and pa-
rameters for the safe and effective practice of telemedicine
on current evidence. They are not intended to substitute for
independent medical judgments that pertain to individual
circumstances.
Both referring providers and consultants (hereafter referred
to as providers) shall exercise their professional judgment
regarding the appropriateness of telemedicine on a case by
case basis, taking into account the presenting condition, their
ability to make a definitive diagnosis, and their comfort and
expertise. Providers shall observe relevant practice guidelines
and position statements developed by the American Academy
of Dermatology and other related professional organizations.
Preliminary considerations
PATIENT–PROVIDER RELATIONSHIP. Providers shall conform
to all applicable state and federal regulations that pertain to
the practice of medicine, including the establishment of a
provider–patient relationship and the appropriate conditions
for making diagnostic and treatment decisions—including
prescribing. If the patient does not have a primary care pro-
vider, the consulting provider should recommend appropriate
options to assure continuity of care. Practice organizations
should establish standard operating procedures and work-
flows for telemedicine consults consistent with prevailing
rules and norms.
INFORMED CONSENT. Before the initiation of a telemedicine
encounter, the provider or designee shall secure patient con-
sent to be treated, as required by local or state regulations. This
can be done in writing or verbally, and it should include an
explanation of the benefits and risks of telemedicine en-
counters. The language shall be simple and understandable by
the average patient.
This explanation shall include the following:
. The nature of the telemedicine encounter, including any
technical limitations or potential for disruption and
contingency plans.
. Procedures for coordination of care with other profes-
sionals, as indicated.
. Protection of patient identifiable information.
. Credentials of the distant site teledermatologists.
. Explicit emergency plan for patients in settings without
access to clinical staff.
. Conditions under which telemedicine services may be
terminated and a referral made to in-person care.
. Billing arrangements, if appropriate.
PHYSICAL ENVIRONMENT. The provider shall determine the
level of distraction (e.g., noise), infringement on privacy, and
other environmental conditions that may affect the quality of
the encounter. In live-interactive encounters, the following
conditions shall be observed:
. Both patient and provider room/environment shall en-
sure visual and auditory privacy.
. All persons in the examination room at both sites shall be
identified before the consultation; and it shall be verified
that all are visible and can be heard.
. Seating and lighting should be designed for both comfort
and professional interaction. Background light from
windows or other sources should be minimized.
. Cameras should be placed on a secure, stable platform
to avoid unnecessary movement during the videocon-
ferencing session and should be placed at the same el-
evation as the eyes with the face clearly visible to the
other person.
Telemedicine management of the patient. Providers shall de-
termine the appropriateness of telemedicine on a case-by-case
basis, and whether the patient must be seen in person and for
what purpose. This information shall be documented in the
patient’s record consistent with relevant standards in evalu-
ating the patient.
PATIENT EVALUATION AND EXAMINATION. The provider shall
obtain the data necessary for making a diagnosis, differential
diagnosis, work-up if appropriate, and treatment plan, in-
cluding the following:
ATA PRACTICE GUIDELINES FOR TELEDERMATOLOGY
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. Identifying information (e.g., age, gender, race)
. Chief complaint(s)
. History of present illness (including location, description,
size, quality, severity, duration, timing, and context
modifying factors such as prior treatments and responses
to treatments)
. Associated signs and symptoms
. Medical history, if pertinent
. Family history, if pertinent
. Medications
. Allergies, including nature, severity of reaction, and
treatment
. Adequate diagnostic quality images, as available
. Diagnostic data (e.g., obtained via self-report or access to
databases) and laboratory test results
Special Considerations: The referring and consulting pro-
viders shall decide whether to exclude certain types of cases
that require special consideration:
. Full body examination: A full body skin scan using vid-
eoconferencing (VTC) or store-and-forward (S&F) is
feasible, but it may not show all skin lesions and surfaces
with sufficient detail. Enhanced lighting, multiple im-
aging, and several angles may be helpful.
. Hair-bearing skin: The scalp and other areas with a sig-
nificant amount of hair may need to have hair physically
displaced or removed, and special lighting may enhance
viewing conditions.
. Pigmented lesions: Pigmented lesions may present a di-
agnostic challenge and should require a higher index of
suspicion when interpreting. Peripheral devices such as
dermatoscopes and confocal microscopy may be incor-
porated into teledermatology consultations.1,27,50,74
. Mucosal lesions: Mucosal lesions and orifices, including
genitalia, often require special attention to lighting and
exposure to allow examination.
. Skin color: Lighting and background conditions may
change the color of skin lesion captured in images.
FOLLOW-UP AND CARE COORDINATION. Continuity of care is
a critical element in quality of medical care and patient
well-being. Hence, teledermatologists should make every
attempt to identify the patient’s usual provider and local
medical resources to coordinate care and make referrals
as indicated.
The teledermatologist shall communicate results of the
encounter to the patient’s referring provider and/or to the
patient, using secure electronic methods in addition to verbal
communication in live-interactive encounters.
A follow-up plan after the encounter shall be developed
and communicated with the patient and/or the referring
provider. This includes any required follow-up, referrals, as
well as clinical signs that signify a significant exacerbation.
Laboratory and other diagnostics ordered shall be followed up
in a timely manner with the patient and their providers, as
indicated and necessary.
DOCUMENTATION. Each patient encounter shall be docu-
mented and maintained in a secure, HIPAA (Health Insurance
Portability and Accountability Act) compliant form and
location. Documentation shall include at a minimum the
diagnosis and/or differential diagnosis and recommended
management/treatment plan and shall include a summary of
the findings. Documentation shall adhere to all medical–legal
standards of care, and, if appropriate, insurance requirements
for future review and audit. Providers shall maintain up to
date business associate agreements with technology suppliers
and other vendors who have access to patient’s personal
health information.
Language used to document the encounter may include
‘‘Based on the images and history provided, my impression is
as follows.’’
Recording of live-interactive encounters is optional, un-
less it is required in particular settings. Patient consent is
necessary when the recording is made for quality assurance,
training, or research purposes. A written record of the con-
sult shall be kept at least at one site (referring provider
or consultant).
In S&F encounters, electronic, faxed, mailed, or e-mailed
notes shall become part of the patient’s medical record, in-
cluding any teledermatologist annotations.
The referring provider and teledermatologist should es-
tablish an explicit process for patients to request copies of
their telemedicine encounters.
Quality. Providers shall use a continuous quality improve-
ment program, including a clinical oversight process. The
quality improvement program includes
. Technical or administrative failures
. Appropriateness of virtual encounter
. Patient and/or provider satisfaction
. Patient outcomes
. Pathology or imaging results
. Recommendations for follow-up
Ethical considerations. Telemedicine practice shall conform
to the same professional ethics that govern in-person care.
Telemedicine providers shall incorporate ethical statements
MCKOY ET AL.
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and policies and legal/regulatory requirements into their
standard operating procedures, including the following:
. An explicit code of ethics.
. Compliance with federal, state, and jurisdictional laws
and regulations, and institutional policies.
. Nondiscrimination clause regarding denial of service to
individuals on the basis of location, socioeconomic sta-
tus, disease or disability, gender, gender preference or
sexual orientation, ethnicity, national origin, or religious
affiliation.
. Provision of service should not be conditional upon re-
ceipt of payment by the patient.
Direct-to-patient care. Based on the limited data available
from the emerging practice of direct-to-patient teledermatology
and some potential concerns regarding quality, third-party
benefits, follow-up, and disclosures, anyone practicing direct-
to-patient teledermatology shall develop and implement an
explicit quality assurance plan and proper disclosures. The
disclosure can be posted on a Web site, software application, or
other information source, and should include basic information
on professional qualifications, credentialing, and privileging;
the nature of the service provided (such as consultations, re-
ferrals, and follow-up); participation in networks or health
systems; and patient-relevant information such as quality as-
surancemechanisms in place and patient access to their records.
TECHNICAL GUIDELINES
Communication modes and applications. All efforts shall be
taken to use appropriate ICT modalities with authentication,
verification, confidentiality, and security arrangements and
with full compliance with HIPAA laws. Software platforms
should not be used when they incorporate social media.
Devices and equipment. Devices shall have up-to-date anti-
virus software and a system-wide firewall with security pat-
ches and updates on the operating system and third-party
applications.
Providers/organizations shall use device management soft-
ware to provide consistent oversight of applications, devices,
and data configurations and security.
Organizations and providers shall ensure that equipment
and connectivity are functioning properly with regular testing
and maintenance.
Image quality. Image quality is essential for providing tele-
dermatology service. This applies to both synchronous and
asynchronous encounters. The following technical specifica-
tions shall be observed:
REQUIREMENTS FOR REAL-TIME VIDEOCONFERENCING (SYNCHRO-
NOUS ENCOUNTERS). The technology shall meet the following
specifications:
. H.264 video compression standard or higher80
. H.323 compliant81
. H.261 video compression standard compatibility82
. G.711 audio compression standard or higher83
. Live video resolution 4CIF (704 · 480) or higher
. Content resolution XGA (1024 · 768) or higher
. Capability of connecting at 384 kbps running 4CIF@30fps
. Minimum of 384 kbps connection speed between referral
and consultant sites.
. Different technologies may render different video quality
at the same bandwidth; hence, each endpoint shall use
bandwidth sufficient to achieve clinical quality.
. Where practical, providers may recommend preferred
videoconferencing software and/or video and audio hard-
ware to the patient, as well as providing any relevant soft-
ware and/or hardware configuration considerations.
. The providers and patients may use link bandwidth test
tools to determine connectivity before starting the ses-
sion to ensure sufficient quality of service.
. Wired links provide the most reliable connectivity on the
Internet, and they should be used when available.
. The videoconference software should adapt to changing
bandwidth availability without losing the connection. If
feasible, redundant systems should be in place.
Lighting. Background lighting should be minimized, and
additional indoor lighting using fluorescent daylight or full-
spectrum bulbs may be needed to augment the illumination
device on the examination cameras.
Views. The imager should hold the camera at a distance to
show the general distribution of the skin lesion(s) before ob-
taining close-up images (usually about 24’’ for most body
areas). When moving the camera to show the distribution and
other details, the imager should request feedback regarding
the speed of camera movement from the dermatologist to
ensure adequate image quality. Oblique views may be in-
cluded to show skin surface changes.
Positioning. If the camera does not contain an image viewer,
it is important to position the patient (as feasible) in between the
camera and the videoconference monitor in one line of sight.
Verbalization of body regions being examined. The imager
shall identify the part of the body being imaged, noting im-
portant characteristics such as size, color, and appearance
of skin.
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Focus. Camera angle must be perpendicular to the skin for
close-up images, noting the distance to the skin lesion(s), and
the camera must be held as still as possible.
Freeze-frame capture. Most video cameras are equipped with
a freeze-frame feature, which is useful for diagnosis, espe-
cially when bandwidth (connectivity speed) is low. Freeze-
frames allow the dermatologist to appreciate fine features of
skin lesions and minimize image degradation that occurs
when scanning with the camera.
Color. Viewing devices may be color calibrated. A Macbeth
color chart may be useful.
Other. Avoid distracting jewelry and clothing.
Use measurement tools to show size and distribution, as
appropriate.
REQUIREMENTS FOR ASYNCHRONOUS IMAGING
Digital cameras. Digital cameras shall be used for image
acquisition, with a minimal resolution of 1024 · 768 pixels
(0.8 megapixel), preferably 3264 · 2448 pixels (8 megapixel)
or greater.
Macro mode. Macro mode capability is ideal (close-up mode
or ‘‘flower’’ image).
Background. Use a solid, neutral color with a nonreflective
surface.
Lighting. Diffuse, indirect light is optimal, using fluores-
cent daylight or full-spectrum bulbs (avoid incandescent).
If outdoors, use well-lit areas or evenly shaded areas if
sunny.
Flash. Use flash to help eliminate shadows, but it may cause
white out if too close.
Compression. Use JPEGmedium or low setting (nomore than
20:1).
Focus. Adjust camera and patient to have camera angle
perpendicular to the skin lesions being imaged. Use autofocus
with area of interest in center of frame. If not possible, focus
first on the area of interest, depress shutter button half-way to
focus, and then move the camera to center the image before
fully depressing shutter button.
Color. Viewing devices may be color calibrated. Macbeth
color chart may be useful.
White balance. The imaging device shall be calibrated for
white balance by taking a picture of white or gray card. The
image can be used to set the white balance by accessing
custom white balance (typically available under camera set-
tings). The white balance calibration should be recalibrated if
there is a change in the physical location of the imaging de-
vice or lighting in the room.
Views. A chaperone or legal guardian should be used as
required or appropriate.
If more than one area is involved, all regions involved
should be included. Take images to show location and ar-
rangement of lesion(s). Take several views.
. Far—entire body or obvious region.
. Medium—include an anatomical landmark such as the
navel or hand.
. Close-up—if the camera has a macro capacity (the ‘‘flower’’
image), an image can be taken within 18 inches from the
skin; otherwise, use the optical zoom, if available for a
close-up. Use perpendicular and oblique views for close-up.
Complementary views should be included. For example, if
the hands are involved, take photos of the feet, knees, and
elbows (additional examples located in the ATA Quick Guide
to S&F Teledermatology for Referring Providers) (Appendix).3
Peripheral devices such as dermatoscopes and confocal
microscopy may be incorporated into teledermatology con-
sultations. Images should be obtained using a hybrid or po-
larized dermatoscope.
Dermoscopy images may be taken with a dermatoscope <2
inches from the skin (noncontact mode) and touching the skin
after cleaning the instrument and skin with alcohol pads
(contact mode) to improve luminance.
Distracting jewelry and clothing should be removed before
imaging.
Lesions should be identified. Identification markers should
be placed adjacent to the lesion without covering any portion
of it. On the skin: Lesions can be identified using adhesive
labels, surgical tape, washable markers, or other removable
tools. Before sending the image, the user should add a digital
circle, box, or arrow to the image.
A ruler should be included in each image (general and
close-up) in close proximity to the lesion so that size/extent
can be determined from the image.
Images shall not be altered in any way after taken.
Images, transmitted text, and teledermatologist response
shall become part of a secure, retrievable medical record.
Images should be reviewed during the acquisition process to
ensure acceptable quality. Send only helpful and clear images
to the consultant.
MOBILE DEVICE USE
Device camera. All image acquisition details described above
for digital cameras apply to mobile device cameras.
MCKOY ET AL.
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Applications/software. Applications (apps) shall allow for
images and medical information to be uploaded in a secure,
HIPAA-compliant, and encrypted protocol, such as the Ad-
vanced Encryption Standard (AES), accessible only by secure
registration and password; may include a protocol for reim-
bursement, and downloadable to an electronic patient record.
Image display. Monitors for viewing images shall have a
minimum of 1024 · 768 pixel resolution, minimum contrast
ratio of 500:1, minimum luminance of 250 cd/m2, and mini-
mum dot pitch of 0.19. A dedicated monitor or set of monitors
may be used. Color calibration may be used to ensure the
reliable color rendition.
Privacy. All patient identifiable information (protected
health information) shall be treated as confidential and pro-
tected from unauthorized use and shall meet recognized
standards.
Individuals in charge of technology shall familiarize
themselves with the technologies available regarding com-
puter and mobile device security.
When using a mobile device, special attention shall be
placed on the privacy of information being communicated or
stored.
Devices shall be configured to utilize an inactivity timeout
function that requires a password or re-authentication to re-
gain access. This timeout should not exceed 15–20min. Mo-
bile devices with patient information should be kept in the
possession of the provider when traveling or in an uncon-
trolled environment.
Providers should have the capability to remotely disable or
delete stored information on their mobile device if lost or
stolen.
Patients should be informed that some software and mobile
apps designed for patient use separately and permanently
store or create copies of images on equipment or device,
creating a possible security/privacy risk.
Access to videoconferencing sessions shall be limited to
authorized users.
Whole disk encryption (FIPS 140-2, known as the Federal
Information Processing Standard) shall be used when storing
protected health information on the hard drive of the pro-
viders’ computers.
Patients should be informed regarding the best ways to
protect their devices and data, especially when using software,
Web-based or mobile apps on their own.
Providers and patients shall discuss any intention to record
encounters or images, the purpose or use of the recording,
how the information will be stored, and how privacy will
be protected. Recordings shall be encrypted for maximum
security. Access to the recordings shall be limited strictly to
authorized users.
ADMINISTRATION GUIDELINES
Security. Teledermatologists shall keep a record of all users
of electronic records to assure that only those with legitimate
clinical need can have such access as stipulated by law. Use of
such records for administrative, research, or teaching shall be
defined and approved by appropriate bodies, such as institu-
tional review boards.
System administrators shall
. Keep database files in encrypted form at rest and in
transit.
. Have the vendor pass a security audit and sign a Business
Associate Agreement if data storage is cloud-based.
Licensing and credentialing. Providers shall follow federal,
state, and local regulatory and licensure requirements related
to their scope of practice, and shall abide by state board and
specialty training requirements. A provider shall ensure that
he/she is duly licensed and credentialed in a jurisdiction in
which the patient is physically located. Providers shall prac-
tice within the scope of their licensure and shall observe all
applicable state and federal legal and regulatory requirement
regulations related to the use of telemedicine.
The practice of medicine shall be defined as occurring where
the patient is located at the time of the physician–patient en-
counter. As such, the provider shall be under the jurisdiction of
the state medical board where the patient is located.
Providers who wish to be licensed in multiple states or
‘‘interstate medical licensure’’ shall be aware of regulations
and options. For example, the Federation of State Medical
Boards (FSMB) has drafted the ‘‘Interstate Medical Licensure
Compact’’ to provide an expedited licensure process for eli-
gible physicians. The Compact is expected to ease the process
of gaining licensure in multiple states.
According to the Compact, eligible physician designates
the state of principal licensure and selects the other member
states where a medical license is desired. The state of princi-
pal licensure would verify the physician’s eligibility and
provide credential information to the Interstate Commission,
which collects any applicable fees and transmits the physi-
cian’s information and licensure fees to the additional states.
Subsequently, the physician would be granted a license. The
Compact does not change the state’s existing definition of
a physician within its Medical Practice Act nor the require-
ments for state medical licensure. The enactment of the
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Compact in additional states is a dynamic process, and the
practitioners should refer to www.licenseportability.org for
the latest updates.
Liability. Teledermatologists shall be cognizant of the lia-
bility that is incurred in medical practice, whether in-person
or via electronic means.
Providers should verify that their medical liability insur-
ance policy covers telemedicine services, including services
provided across state lines, if applicable.
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Appendix Definitions3
Teledermatology refers to thedeliveryofdermatology specialty
services (advice, diagnosis, treatment planning, and education) to
patients and other healthcare providers remotely using ICT.
Synchronous teledermatology refers to the remote provi-
sion of services online or with both provider and patient
communicating at the same time.
Asynchronous (or S&F) teledermatology refers to the re-
mote provision of service at different times.
Hybrid teledermatology refers to utilizing both S&F and
videoconferencing modes for teledermatology.
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